Related Experiment Video
Updated: Aug 6, 2026

Antigenic Liposomes for Generation of Disease-specific Antibodies
Published on: October 25, 2018
Enhancing immunogenicity by limiting susceptibility to lysosomal proteolysis
Lélia Delamarre1, Rachael Couture, Ira Mellman
1Department of Cell Biology and Section of Immunobiology, Ludwig Institute for Cancer Research, Yale University School of Medicine, New Haven, CT 06520, USA.
Protein antigen stability to lysosomal breakdown influences immune responses. Less digestible antigens are more immunogenic, enhancing T cell priming and antibody production for potential vaccine design.
Area of Science:
- Immunology
- Biochemistry
Background:
- T cells recognize processed protein fragments (peptides) presented by antigen-presenting cells.
- The precise mechanisms governing peptide selection and antigen immunogenicity remain incompletely understood.
- Predicting and manipulating antigen immunogenicity is challenging.
Purpose of the Study:
- To investigate the role of lysosomal proteolysis susceptibility in determining protein antigen immunogenicity in vivo.
- To compare the immunogenicity of proteins with identical sequences and structures but varying resistance to lysosomal degradation.
Main Methods:
- Immunization of mice with model antigens (RNase, horseradish peroxidase) adsorbed onto aluminum hydroxide adjuvant.
- Measurement of serum IgG responses as an indicator of antigen presentation on MHC class II molecules.
- Assessment of CD4+ T cell priming in vivo.
Main Results:
- Proteins with greater resistance to lysosomal proteolysis were significantly more immunogenic.
- Less digestible antigen forms induced more efficient T cell priming and robust antibody responses.
- Identical protein sequences and structures yielded different immunogenicities based on proteolysis resistance.
Conclusions:
- Antigen stability against lysosomal proteolysis is a critical factor in determining in vivo immunogenicity.
- This finding has significant implications for the rational design of vaccines.
- Manipulating antigen stability could enhance vaccine efficacy.
More Related Videos
08:14Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting
Published on: October 26, 2018
13:53Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
Published on: December 19, 2020